Clinical Trials List
Protocol NumberF1J-MC-HMDW
Not yet recruiting
Phase III
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
48 participants
-
Global
560 participants
